Claret Capital Secures €350M for Fund IV, Bolsters European Tech
September 11, 2025, 3:35 am
Location: United Kingdom, England, London
Employees: 11-50
Founded date: 2017
Total raised: $8.48M
Claret Capital Partners, a leading European growth debt fund manager, announced its Fund IV second close. The firm secured over €350 million. Total assets under management now exceed $1 billion. This capital targets high-growth European SMEs in technology, life sciences, and climate tech. Fund IV has already invested in 12 new companies. Key investors include major pension funds and sovereign wealth funds. An innovative ELTIF vehicle also attracted private wealth. This signifies strong demand for flexible growth capital. It fuels European innovation. A final close is expected in 2026, boosting the firm's deployment capabilities. This strategic move cements Claret's market position.
Claret Capital Partners marks a significant milestone. The European growth debt manager announced the second close of its Fund IV. Commitments now exceed €350 million. This achievement elevates the firm’s total assets under management past $1 billion. It solidifies Claret’s standing as a premier independent growth debt provider.
The new capital will empower innovative European businesses. Claret focuses on critical sectors. These include technology, life sciences, and climate tech. The firm backs small and medium-sized enterprises (SMEs) across the continent. These companies drive Europe's economic future. They require flexible, non-dilutive financing. Claret provides this essential support.
Since its inception in 2013, Claret's impact has been substantial. The firm has deployed over €1.2 billion. It has supported more than 190 SMEs. This track record demonstrates consistent market leadership. Claret’s expertise spans over 25 years in technology financing. They help entrepreneurs and private equity investors. Growth debt minimizes equity dilution. It offers a vital growth pathway.
Fund IV is actively deploying capital. Since March 2025, it has added 12 new companies. These include prominent names like Fund Recs, Mindler, Montonio, PRODA, SIDES, ValueBlue, and Yseop. This swift deployment highlights strong sourcing capabilities. It also reflects robust market opportunities. European innovation thrives on such focused investment.
The second close attracted a diverse array of investors. Commitments came from major institutions. These include Banca March, a significant Canadian pension fund, and a well-established German foundation. British Business Bank, The European Investment Fund (EIF), ISIF, and KfW Capital also participated. Wachstumsfonds Deutschland, a top VC fund of funds, joined the ranks. This broad support underscores confidence in Claret’s strategy.
Beyond direct fund commitments, additional firepower emerges. Certain Fund IV Limited Partners established discretionary co-investment partnerships. These total over €115 million. This capital targets ambitious companies. It allows Claret to support larger opportunities. This provides further strategic depth for European growth companies.
An innovative ELTIF (European Long-Term Investment Fund) vehicle played a key role. It facilitated private wealth investor participation. This broadens the investor base. It allows wealth management clients to access high-growth European assets. Banca March utilized this structure exclusively for its clients. This initiative expands investment access. It aligns with growing interest in private market investments. IQ-EQ serves as the AIFM for both institutional and ELTIF vehicles.
The demand for growth debt continues to surge. Europe's dynamic tech and life sciences sectors need tailored financing solutions. Traditional equity funding can be dilutive. Growth debt offers an alternative. It allows founders to retain more ownership. This fuels sustainable growth for scaling companies. Claret Capital meets this critical market need.
The firm anticipates a final close for Fund IV in 2026. This future milestone will further enhance Claret's investment capacity. It signals continued commitment to European enterprises. The strategic capital injections from Fund IV reinforce the continent's innovation ecosystem. This builds economic resilience and sovereignty.
Claret Capital Partners remains dedicated. It partners with visionary founders. It supports management teams. These leaders drive innovation across Europe. Their success powers the region's competitive edge. Claret’s latest fund close directly contributes to this vital mission. It shapes Europe’s technological and scientific future.
Claret Capital Partners marks a significant milestone. The European growth debt manager announced the second close of its Fund IV. Commitments now exceed €350 million. This achievement elevates the firm’s total assets under management past $1 billion. It solidifies Claret’s standing as a premier independent growth debt provider.
The new capital will empower innovative European businesses. Claret focuses on critical sectors. These include technology, life sciences, and climate tech. The firm backs small and medium-sized enterprises (SMEs) across the continent. These companies drive Europe's economic future. They require flexible, non-dilutive financing. Claret provides this essential support.
Since its inception in 2013, Claret's impact has been substantial. The firm has deployed over €1.2 billion. It has supported more than 190 SMEs. This track record demonstrates consistent market leadership. Claret’s expertise spans over 25 years in technology financing. They help entrepreneurs and private equity investors. Growth debt minimizes equity dilution. It offers a vital growth pathway.
Fund IV is actively deploying capital. Since March 2025, it has added 12 new companies. These include prominent names like Fund Recs, Mindler, Montonio, PRODA, SIDES, ValueBlue, and Yseop. This swift deployment highlights strong sourcing capabilities. It also reflects robust market opportunities. European innovation thrives on such focused investment.
The second close attracted a diverse array of investors. Commitments came from major institutions. These include Banca March, a significant Canadian pension fund, and a well-established German foundation. British Business Bank, The European Investment Fund (EIF), ISIF, and KfW Capital also participated. Wachstumsfonds Deutschland, a top VC fund of funds, joined the ranks. This broad support underscores confidence in Claret’s strategy.
Beyond direct fund commitments, additional firepower emerges. Certain Fund IV Limited Partners established discretionary co-investment partnerships. These total over €115 million. This capital targets ambitious companies. It allows Claret to support larger opportunities. This provides further strategic depth for European growth companies.
An innovative ELTIF (European Long-Term Investment Fund) vehicle played a key role. It facilitated private wealth investor participation. This broadens the investor base. It allows wealth management clients to access high-growth European assets. Banca March utilized this structure exclusively for its clients. This initiative expands investment access. It aligns with growing interest in private market investments. IQ-EQ serves as the AIFM for both institutional and ELTIF vehicles.
The demand for growth debt continues to surge. Europe's dynamic tech and life sciences sectors need tailored financing solutions. Traditional equity funding can be dilutive. Growth debt offers an alternative. It allows founders to retain more ownership. This fuels sustainable growth for scaling companies. Claret Capital meets this critical market need.
The firm anticipates a final close for Fund IV in 2026. This future milestone will further enhance Claret's investment capacity. It signals continued commitment to European enterprises. The strategic capital injections from Fund IV reinforce the continent's innovation ecosystem. This builds economic resilience and sovereignty.
Claret Capital Partners remains dedicated. It partners with visionary founders. It supports management teams. These leaders drive innovation across Europe. Their success powers the region's competitive edge. Claret’s latest fund close directly contributes to this vital mission. It shapes Europe’s technological and scientific future.